BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
I was very excited but indeed intimidated when I first joined but with the support of my team and manager, I slowly started to finding my feet. Now with the intimidation gone, the excitement remains and I am thrilled to be a member of this team working on products that impact patients' lives
Quelles sont les meilleures choses à propos de votre équipe?
Open communication and collective dedication to collaboration.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Openness, and willingness to foster employee personal growth
Quelle est la meilleure partie de votre programme de rémunération?
Health insurance and Group pension plan
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
The inviting and engaging office space and work environment in general.
Qu’est-ce qui vous rend le plus heureux au travail?
Being a member of a team working on a product/products that changes people's life is a lifelong dream of mine! It is becoming a reality at BRT.
Other Employee Reviews for BlueRock Therapeutics
×